6,9.ALPHA.-DIFLUORO-11.BETA.,16.ALPHA.,17.ALPHA.,21-TETRAHYDROXYPREGNA-1,4,6-TRIENE-3,20-DIONE 16,17-ACETONIDE 21-ACETATE
UNII TAW8Q0NC0W
Substance Identification & Data
This profile provides standardized clinical and technical data for 6,9.alpha.-difluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4,6-triene-3,20-dione 16,17-acetonide 21-acetate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TAW8Q0NC0W.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 105918-35-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H30F2O7 XLVHOCJKNPCAQO-YRCSZXIRSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6,9.alpha.-difluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4,6-triene-3,20-dione 16,17-acetonide 21-acetate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.